Literature DB >> 24008825

Prospective multicentre evaluation of the direct nitrate reductase assay for the rapid detection of extensively drug-resistant tuberculosis.

Anandi Martin1, Belen Imperiale, Pascaline Ravolonandriana, Ahmet Yilmaz Coban, Alper Akgunes, Aamer Ikram, Luqman Satti, Mathieu Odoun, Pooja Pandey, Manvi Mishra, Dissou Affolabi, Urvashi Singh, Voahangy Rasolofo, Nora Morcillo, Peter Vandamme, Juan Carlos Palomino.   

Abstract

OBJECTIVES: To perform a multicentre study evaluating the performance of the direct nitrate reductase assay (NRA) for the detection of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in sputum samples.
METHODS: The study was conducted in six laboratories performing tuberculosis diagnosis that were located in six different countries. The NRA was performed directly on sputum samples in parallel with the reference method used at each site. Detection of resistance was performed for rifampicin, isoniazid, ofloxacin and kanamycin.
RESULTS: Excellent agreement was obtained for all drugs tested at the majority of sites. The accuracy was 93.7%-100% for rifampicin, 88.2%-100% for isoniazid, 94.6%-100% for ofloxacin and 100% for kanamycin. The majority of NRA results were available at day 21 for sites 1, 2 and 5. Site 3 had a turnaround time of 13.9 days, at site 4 it was 18.4 days and at site 6 it was 16.2 days. The contamination rate ranged between 2.5% and 12%.
CONCLUSIONS: Rapid detection of drug resistance by the direct NRA on sputum smear-positive samples was accurate and easy to implement in clinical diagnostic laboratories, making it a good alternative for rapid screening for MDR and XDR tuberculosis.

Entities:  

Keywords:  Mycobacterium tuberculosis; multidrug resistance; nitratase

Mesh:

Substances:

Year:  2013        PMID: 24008825     DOI: 10.1093/jac/dkt353

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  5 in total

Review 1.  The medical and surgical treatment of drug-resistant tuberculosis.

Authors:  Gregory L Calligaro; Loven Moodley; Greg Symons; Keertan Dheda
Journal:  J Thorac Dis       Date:  2014-03       Impact factor: 2.895

Review 2.  Phylogenomics of Mycobacterium Nitrate Reductase Operon.

Authors:  Qinqin Huang; Abualgasim Elgaili Abdalla; Jianping Xie
Journal:  Curr Microbiol       Date:  2015-05-17       Impact factor: 2.188

3.  Multicenter evaluation of crystal violet decolorization assay (CVDA) for rapid detection of isoniazid and rifampicin resistance in Mycobacterium tuberculosis.

Authors:  Ahmet Yilmaz Coban; Ahmet Ugur Akbal; Can Bicmen; Ali Albay; Ali Korhan Sig; Meltem Uzun; Deniz Sertel Selale; Nuri Ozkutuk; Suheyla Surucuoglu; Nurhan Albayrak; Nilay Ucarman; Aydan Ozkutuk; Nuran Esen; Ismail Ceyhan; Mustafa Ozyurt; Bayhan Bektore; Gonul Aslan; Nuran Delialioğlu; Alpaslan Alp
Journal:  Sci Rep       Date:  2016-12-16       Impact factor: 4.379

4.  Direct Resazurin Microplate Assay in Drug Susceptibility Testing of Smear-Positive Sputum Samples against Mycobacterium tuberculosis.

Authors:  Noor Izani Noor Jamil; Wan Nor Amilah Wan Abdul Wahab; Ibyhaslin Alyani Ali; Mohammad Lukman Yahaya
Journal:  Malays J Med Sci       Date:  2018-12-28

5.  Genotype analysis of ofloxacin-resistant multidrug-resistant Mycobacterium tuberculosis isolates in a multicentered study from India.

Authors:  Anamika Gupta; Pallavi Sinha; Sunita Rathod; Siva Kumar Shanmugam; K R Uma Devi; Shampa Anupurba; Vijay Nema
Journal:  Indian J Med Res       Date:  2020-04       Impact factor: 2.375

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.